Global Arthritis Monoclonal Antibodies Markets 2022-2031: Focus on Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia

MLA

“Global Arthritis Monoclonal Antibodies Markets 2022-2031: Focus on Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia.” GlobeNewswire, 23 June 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.708000088&authtype=sso&custid=ns315887.

APA

Global Arthritis Monoclonal Antibodies Markets 2022-2031: Focus on Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia. (2022, June 23). GlobeNewswire.

Chicago

GlobeNewswire. 2022. “Global Arthritis Monoclonal Antibodies Markets 2022-2031: Focus on Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia,” June 23. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.708000088&authtype=sso&custid=ns315887.